Canopy Growth Announces Industry Veteran Christelle Gedeon As New Chief Legal Officer

Gedeon's demonstrated cannabis and commercial expertise will further Canopy Growth's Strategy for North American Cannabis Leadership

SMITHS FALLS, ON, Aug. 2, 2022 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, is pleased to announce that the appointment of Christelle Gedeon, Ph.D., as the Company's new Chief Legal Officer.

Named one of Canada's Law Department Leaders of the Year and listed on the Legal 500 GC Powerlist in 2020, and the 2019 Canadian General Counsel Awards Tomorrow's Leader, Christelle is an accomplished commercial lawyer and strategist with more than a decade of legal and strategic experience including most recently as the Chief Legal Officer and Corporate Secretary for The Metals Company (TMC). Prior to this, she served as the Chief Legal Officer and Corporate Secretary at Aphria, Inc., where she oversaw the reverse takeover of Tilray, Inc.

"Christelle is a proven leader in the legal and cannabis industries, and we are excited to have her join Canopy Growth as we continue to build the leading brand-driven cannabis company in North America," said David Klein, CEO of Canopy Growth. "As a company, we have set clear priorities including achieving profitability while advancing our competitive positioning through a premium focus in Canada, high-impact CPG brands, and the continued growth of our U.S. THC ecosystem. I am confident that Christelle's commercial and legal acumen will be key to further bringing our strategy to fruition."

In addition to her demonstrated expertise in the cannabis industry, Christelle brings experience with complex regulatory structures, intellectual property management, corporate governance, government relations, and strategic acquisitions. She has also had a direct role in the completion of more than 50 mergers, acquisitions, and strategic investments including during her time as a partner at Fasken, a leading Canadian law firm, where she advised life sciences clients on commercial, regulatory, and government affairs matters.

Christelle received her LL.B/B.C.L. from McGill University and is a member in good standing of both the Ontario and Quebec bars. She is also a registered trademark agent in and holds a Ph.D. in Clinical Pharmacology and Toxicology from the University of Toronto. Her appointment to the role of Chief Legal Officer at Canopy Growth is effective immediately.

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp-derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information, visit www.canopygrowth.com.

SOURCE Canopy Growth Corporation

Media Contact: Jennifer White, [email protected]; Investor Contact: Tyler Burns, Director, Investor Relations, [email protected]